Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
331
331 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- QLS7305Phase 21 trial
Qilu Pharmaceutical Co., Ltd. · IgAN - IgA Nephropathy, Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN), C3 Glomerulopathy (C3G)
- REGN15505Phase 21 trial
Regeneron · Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)
- REGN21353Phase 21 trial
Regeneron · Metastatic Castration-Resistant Prostate Cancer, mCRPC
- RG002C0106Phase 21 trial
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. · IgA Nephropathy (IgAN)
- RMC-035Phase 21 trial
Guard Therapeutics AB · Kidney Injury Following Open-Chest Cardiac Surgery
- RS-113Phase 21 trial
R-Pharm International, LLC · Metastatic Castration-resistant Prostate Cancer
- RV001VPhase 21 trial
RhoVac APS · Prostate Cancer Recurrent
- RYZ711Phase 21 trial
RayzeBio, Inc. · Prostate Cancer (Adenocarcinoma), Adenocarcinoma of the Prostate, Metastatic Castration-resistant Prostate Cancer (mCRPC)
- selected combination of tinengotinibPhase 21 trial
TransThera Sciences (Nanjing), Inc. · Prostate Cancer (CRPC)
- SFG-02Phase 21 trial
Juro Sciences Inc. · Participants With Underactive Bladder (UAB)
- SHR-4394Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer
- SHR3680Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer
- SNS-101anti-VISTAPhase 21 trial
Sensei Biotherapeutics, Inc. · Solid Tumor, Adult, Advanced Solid Tumor, Head and Neck Cancer
- SPH3127Phase 21 trial
Shanghai Pharmaceuticals Holding Co., Ltd · Diabetic Kidney Disease
- ST-067Phase 21 trial
Simcha IL-18, Inc. · Cancer, Solid Tumor, Melanoma
- ST101Phase 21 trial
Sapience Therapeutics · Glioblastoma, Melanoma Stage IV, Breast Cancer
- STM-416Phase 21 trial
SURGE Therapeutics · Non-muscle-invasive Bladder Cancer
- SV-102Phase 21 trial
Syncromune, Inc. · Metastatic Castration-resistant Prostate Cancer
- SX-682Phase 21 trial
Syntrix Biosystems, Inc. · Metastatic Castration-resistant Prostate Cancer
- Tacrolimus prolonged releasePhase 21 trial
Astellas · Intestine Transplantation, Kidney Transplantation, Lung Transplantation
- TB511Phase 21 trial
Twinpig Biolab, Inc. · NSCLC, Prostate Cancer, Colorectal Cancer
- TD001Phase 21 trial
T.O.A.D. Oncology SA · Metastatic Castration-Resistant Prostatic Cancer
- TQB3201Phase 21 trial
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Metastatic Castration-resistant Prostate Cancer
- TRG-200Phase 21 trial
Trigone Pharma Ltd. · Overactive Bladder (OAB)
- TT-10Phase 21 trial
Portage Biotech · Renal Cell Cancer, Castrate Resistant Prostate Cancer, Non Small Cell Lung Cancer
- TY-302Phase 21 trial
TYK Medicines, Inc · Metastatic Castration-resistant Prostate Cancer (mCRPC)
- VB15010Phase 21 trial
Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Cancer, Neoplasms, Neoplasms, Breast
- VEL-101Pegrizeprument, FR104Phase 21 trial
Asahi Kasei Therapeutics, Inc. · Transplantation, Kidney
- VMD-102Single agentPhase 21 trial
VM Discovery, Inc. · Hepatocellular Carcinoma (HCC), Metastatic Uveal Melanoma, Renal Cell Carcinoma (RCC)
- VX-407Phase 21 trial
Vertex Pharmaceuticals · Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- WAL0921Phase 21 trial
Walden Biosciences · Diabetic Nephropathies, Primary Focal Segmental Glomerulosclerosis, Minimal Change Disease
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.